Analysts Set Cytokinetics, Incorporated (NASDAQ:CYTK) Target Price at $76.88
Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have received an average recommendation of “Moderate Buy” from the eighteen research firms that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy […]
Shares of Cytokinetics, Incorporated (NASDAQ:CYTK – Get Free Report) have received an average recommendation of “Moderate Buy” from the eighteen research firms that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has issued a strong buy […]
